CLS Americas Announces 2nd Order of TRANBERG™ Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center
09 avr. 2024 02h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas received its second order from the National Institutes of Health Clinical Center (NIHCC) for its TRANBERG Thermal Therapy System accessories.
CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation
28 mars 2024 00h30 HE
|
Clinical Laserthermia Systems Americas, Inc.
– CLS Americas today announcedthat ROSE Urology, LLC will begin using the TRANBERG™ Thermal Therapy System to treat prostate cancer patients.
CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System
28 nov. 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas selects Quest International, a global aftermarket technical service provider to OEMs, to provide Service and Logistics to the US market.
CLS Americas States KASRAEIAN Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation
09 nov. 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas today announced that KASRAEIAN Urology located in Jacksonville, FL, will begin treating prostate cancer patients using the TRANBERG™ Laser.
CLS Americas and HALO Diagnostics Initiate Prostate Cancer Clinical Study using TRANBERG Focal Laser Ablation System
07 nov. 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS,and HALO Diagnostics announce 25-patient clinical study using the TRANBERG™ System to perform focal laser ablation on prostate cancer patients.
GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
06 nov. 2023 09h30 HE
|
GT Biopharma, Inc.
BRISBANE, CALIFORNIA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...
CLS Americas Announces Kearney Urology Center will use its TRANBERG Laser to Provide Focal Laser Ablation Treatments to Prostate Cancer Patients
24 oct. 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas announces Kearney Urology Center will use its TRANBERG Laser to treat prostate cancer patients.
CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting
03 oct. 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting
CLS Americas Announces AVANT Concierge Urology has Treated its First Prostate Cancer Patients using the TRANBERG™ Thermal Therapy System
11 mai 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and ORLANDO, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for...
Prostate Health Market to Cross USD 66.86 Billion by 2030 owing to Rise in Cases of Prostate-Related Disorders Globally | Research by SNS Insider
26 avr. 2023 09h20 HE
|
SNS Insider pvt ltd
Pune, April 26, 2023 (GLOBE NEWSWIRE) -- As per the report by SNS Insider, the Prostate Health Market was valued at USD 34.05 billion in 2022, and it is anticipated to grow at a CAGR of 8.8% during...